glp-1 ghrelin JCI Frontiers | The Regulation of

This product is intended solely for laboratory research use

Understanding the Legal Risks of BPC-157 and Other Unapproved Peptides The Peptide Compliance Crisis: Regulatory Enforcement and Liability Risks of BPC-157 The massive commercial rise of regenerative medicine and anti-aging therapies has placed synthetic peptides like BPC-157 (Body Protection Compound-157) at the center of clinical wellness models

Realistic expectations focus on appetite control and metabolic health support, not the dramatic results seen in randomized controlled trials of prescription GLP 1 medications

Additional research will need to delineate dosing, timing, and safety prior to general use in fertility care

[16] HTMLA